2. Gene
  3. TNF - tumor necrosis factor Gene

TNF - tumor necrosis factor Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：肿瘤坏死因子

种属: Macaca mulatta

同用名: TNLG1F; TNF-ALPHA

基因 ID: 715467 | 基因类型: protein coding

关于 TNF

Primary_assembly 4: 137,935,352-137,937,146 reverse strand.Mmul_10:CM014339.1

This gene has 1 transcript (splice variant), 246 orthologues and 8 paralogues.

TNF 基因产物(1)

mRNA Protein Name
NM_001047149.1 NP_001040614.1 tumor necrosis factor

TNF 蛋白结构

TNF

TNF: pfam00229 (104 - 235)

  • 0
  • 100
  • 200
  • 236 a.a.
蛋白主名 其他名称

tumor necrosis factor

ATP-binding cassette, sub-family F (GCN20), member 1

TNF-a

cachectin

tumor necrosis factor (TNF superfamily, member 2)

tumor necrosis factor alpha

tumor necrosis factor ligand 1F

tumor necrosis factor ligand superfamily member 2

重组 TNF 蛋白

目录号 产品名 蛋白编号 纯度
HY-P7303 TNF-alpha/TNFSF2 Protein, Rhesus macaque P48094 (V77-L233) ≥95%

相关产品

Approval
生物活性分子 (19)
目录号 产品名 作用方式
纯度 是否罕见病
HY-12085 Apremilast 99.91% 是
HY-103399 Trovafloxacin mesylate Inhibitor 99.56% 否
HY-N0281 Daphnetin 99.86% 否
HY-B1077 Penfluridol 99.93% 否
HY-13682 Mifamurtide ≥99.0% 否
HY-A0170 Trovafloxacin Inhibitor 98.99% 否
HY-B1201 Tiratricol Inhibitor 99.60% 是
HY-N0066 Eucalyptol Inhibitor ≥98.0% 否
HY-30235A Benzydamine hydrochloride Inhibitor 98.22% 否
HY-B0164 Mizolastine Antagonist 99.82% 否
HY-B0446 Naphazoline hydrochloride 98.12% 否
HY-13682B Mifamurtide sodium 98.19% 否
HY-B0513 Methylthiouracil Inhibitor ≥98.0% 否
HY-111326A Naphazoline nitrate ≥98.0% 否
HY-13682C Mifamurtide TFA ≥98.0% 否
HY-B1615 Clenbuterol Agonist / 否
HY-111326 Naphazoline / 否
HY-30235 Benzydamine Inhibitor / 否
HY-B0164A Mizolastine dihydrochloride Antagonist / 否
抗体抑制剂 (6)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9970 Infliximab Inhibitor 90.30% 否
HY-P9908 Adalimumab Inhibitor 99.62% 否
HY-108847 Etanercept Inhibitor 99.20% 否
HY-P9953 Certolizumab pegol Inhibitor 99.30% 否
HY-P99111 Golimumab 99.71% 否
HY-P99796 Ozoralizumab Inhibitor 99.80% 否
Clinical Phase
生物活性分子 (23)
目录号 产品名 作用方式
纯度 Phase
HY-N3021 D-chiro-Inositol Inhibitor ≥98.0% Phase 4
HY-N8277 Kdo2-Lipid A ammonium 99.00% Phase 4
HY-114360AS1 Taurohyodeoxycholic acid-d4 sodium Inhibitor / Phase 4
HY-11109 Resatorvid Inhibitor 99.95% Phase 3
HY-13743 Roquinimex Inhibitor 99.69% Phase 3
HY-13740 Resiquimod 99.95% Phase 2
HY-16591 Birinapant 99.70% Phase 2
HY-110133 JTE-607 Inhibitor 99.27% Phase 2
HY-15509A Semapimod tetrahydrochloride Inhibitor 98.43% Phase 2
HY-119307 Apratastat Inhibitor 99.67% Phase 2
HY-118250 GSK2245035 99.85% Phase 2
HY-145726 ISIS 104838 Inhibitor / Phase 2
HY-105017 Evodenoson Agonist 99.74% Phase 2
HY-U00179 CDC801 Inhibitor 98.94% Phase 2
HY-114766 Pumafentrine Inhibitor / Phase 2
HY-10172 IMD-0354 Inhibitor 99.51% Phase 1
HY-13518 Piceatannol 98.90% Phase 1
HY-107390 AX-024 Inhibitor 99.29% Phase 1
HY-19717 DCVC Inhibitor 99.83% Phase 1
HY-15507 VGX-1027 Inhibitor 99.76% Phase 1
HY-N0803 Myrcene Inhibitor ≥75.0% Phase 1
HY-107390A AX-024 hydrochloride Inhibitor 99.75% Phase 1
HY-N8691 2',6'-Dihydroxy-4'-methoxydihydrochalcone Inhibitor / Phase 1
抗体抑制剂 (16)
目录号 产品名 作用方式
纯度 Phase
HY-P99252 Itolizumab ≥99.0% Phase 3
HY-P990070 Zigakibart Inhibitor 98.37% Phase 3
HY-P99499 Cetrelimab ≥99.0% Phase 3
HY-P99578 Tanfanercept Inhibitor / Phase 3
HY-P99692 Lenercept Inhibitor / Phase 3
HY-P99772 Onfekafusp alfa / Phase 3
HY-P99670 Iscalimab Inhibitor 99.64% Phase 2
HY-P99315 Ruplizumab Inhibitor 99.84% Phase 2
HY-P99810 Quisovalimab 97.78% Phase 2
HY-P99940 Remtolumab Inhibitor 99.24% Phase 2
HY-P9983 Lintuzumab 98.09% Phase 2
HY-P99704 Licaminlimab Inhibitor 96.10% Phase 2
HY-P99775 Placulumab Inhibitor / Phase 2
HY-P99945 Revdofilimab Activator 99.35% Phase 1
HY-P99178 CTX-471 99.42% Phase 1
HY-P99361 Enavatuzumab Inhibitor ≥95.0% Phase 1
Pre-clinical Phase
生物活性分子 (463)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13453 BAY 11-7082 99.98% 否
HY-N0822 Shikonin Inhibitor 99.80% 否
HY-15648B GSK-J4 99.64% 否
HY-P0224 N-Formyl-Met-Leu-Phe Inhibitor 99.36% 否
HY-108473 CU-CPT 4a Inhibitor 99.34% 否
HY-103490 Takinib 98.92% 否
HY-110203 R-7050 Antagonist 98.55% 否
HY-12326A c-di-AMP disodium Agonist 99.71% 否
HY-P1860 TNF-α (31-45), human 99.77% 否
HY-138682 STING-IN-2 Inhibitor 99.71% 否
HY-123942 Diprovocim Agonist 98.35% 否
HY-13812 QNZ Inhibitor 99.50% 否
HY-133122 UCB-9260 Inhibitor 98.38% 否
HY-122882 HOIPIN-8 99.89% 否
HY-109804 CORM-401 Inhibitor 98.27% 否
HY-126360 Oxazolone ≥98.0% 否
HY-13229 BOC-D-FMK Inhibitor ≥95.0% 否
HY-100339 GSK583 Inhibitor 98.74% 否
HY-N0633 Muscone Inhibitor ≥98.0% 否
HY-N0029 Forsythoside B 99.99% 否
HY-N0297 Sinensetin Inhibitor 99.87% 否
HY-15648F GSK-J4 hydrochloride Inhibitor 99.01% 否
HY-100211 TAPI-2 Inhibitor 99.46% 否
HY-134471 TNF-α-IN-2 Inhibitor 98.75% 否
HY-110353 CU-T12-9 Agonist 98.94% 否
HY-N0509 Astilbin 99.97% 否
HY-N6796 Manumycin A 99.27% 否
HY-N0194 Asiatic acid 99.40% 否
HY-111255 SPD304 Inhibitor 99.58% 否
HY-19744 T6167923 Inhibitor 99.40% 否
HY-N0472 Geraniin Inhibitor 99.84% 否
HY-107737 1,2-DLPC Activator ≥98.0% 否
HY-N0405 Orientin Inhibitor 99.73% 否
HY-107427 PF-3644022 Inhibitor 99.65% 否
HY-N0722 Neochlorogenic acid Inhibitor 99.77% 否
HY-147141 HS-276 Inhibitor 98.59% 否
HY-148141 JPE-1375 Antagonist 99.94% 否
HY-N0043 Ginsenoside Rd Inhibitor 99.88% 否
HY-14622 Necrostatin 2 Inhibitor 99.92% 否
HY-19975 RN-1734 Antagonist 99.86% 否
HY-142618 TNF-α-IN-6 Inhibitor 99.58% 否
HY-125402 GSK-843 99.18% 否
HY-147045 UCB-5307 Inhibitor 97.09% 否
HY-N6607 Tryptanthrin 99.89% 否
HY-N0619 Mulberroside A Inhibitor 99.86% 否
HY-103360 J-113863 Antagonist ≥99.0% 否
HY-15511 Tyrphostin A9 Inhibitor 99.87% 否
HY-101448 TMI-1 99.59% 否
HY-150725 ODN 1585 Inducer / 否
HY-133807 Benpyrine Inhibitor 99.74% 否
HY-N1949 Homoplantaginin Inhibitor 99.90% 否
HY-N0042 Ginsenoside Rc ≥98.0% 否
HY-12700 RO5256390 98.75% 否
HY-110177 SP-100030 Inhibitor 99.86% 否
HY-N7637 Tubuloside B Inhibitor 99.95% 否
HY-108642B AMG-548 dihydrochloride Inhibitor 99.91% 否
HY-101849 Fasentin ≥98.0% 否
HY-103435 Vialinin A Inhibitor 99.89% 否
HY-32018 Cot inhibitor-2 Inhibitor 99.65% 否
HY-131249 MK2-IN-3 Inhibitor 99.58% 否
HY-156454 UCB-6876 Inhibitor 99.96% 否
HY-N0316 Mollugin 99.48% 否
HY-111255A SPD304 dihydrochloride Inhibitor 99.96% 否
HY-N0569 Madecassic acid Inhibitor 99.79% 否
HY-N2350 Cynaropicrin Inhibitor 99.79% 否
HY-N0604 Ginsenoside Rh1 Inhibitor ≥98.0% 否
HY-W010201 Citronellol 98.60% 否
HY-125527 Resolvin D1 99.60% 否
HY-160412 TNFα activity modulator 3 Inhibitor 98.30% 否
HY-P1832A PTD-p65-P1 Peptide TFA 99.14% 否
HY-124750 NecroX-7 Inhibitor 99.69% 否
HY-B0392 (S)-(+)-Rolipram 99.77% 否
HY-130252 YQ128 Inhibitor 99.83% 否
HY-134911 HS-243 Inhibitor 99.88% 否
HY-118922 IW927 Antagonist 99.04% 否
HY-123984 LTβR-IN-1 Activator 99.79% 否
HY-12511 SKF-86002 Inhibitor 99.66% 否
HY-P1847A IKKγ NBD Inhibitory Peptide TFA 98.20% 否
HY-128598 MD2-TLR4-IN-1 Inhibitor 99.62% 否
HY-104073 CAY10602 Activator 98.65% 否
HY-114360A Taurohyodeoxycholic acid sodium Inhibitor 99.60% 否
HY-N4288 4-Methylesculetin Inhibitor 98.21% 否
HY-N7056 4'-Hydroxychalcone Inhibitor 99.66% 否
HY-128686 KAG-308 Agonist 99.88% 否
HY-112275 TNF-α-IN-1 Inhibitor 99.42% 否
HY-113402A Gamma-glutamylcysteine TFA 95.20% 否
HY-139066 Punicic acid ≥98.0% 否
HY-152956 STING agonist-23 Agonist 99.16% 否
HY-N2055 Kaempferol 3-O-sophoroside 99.84% 否
HY-N2086 Ethyl palmitate Inhibitor 99.05% 否
HY-N9965 2'-Fucosyllactose Inhibitor 99.95% 否
HY-12557 γ-Glutamylvaline 99.73% 否
HY-116626 SM-7368 Inhibitor 99.77% 否
HY-N0613 Sauchinone Inhibitor 99.88% 否
HY-N6246 Asperulosidic Acid Inhibitor 99.72% 否
HY-32015 Cot inhibitor-1 Inhibitor 98.45% 否
HY-N0041 Ginsenoside Rb3 Inhibitor 99.12% 否
HY-128348 PK68 Inhibitor 99.92% 否
HY-W082785A L6H21 99.46% 否
HY-N1356 Reticuline Inhibitor 98.91% 否
HY-N2110 Phellopterin 99.94% 否
HY-N9445 Lacto-N-neotetraose 99.71% 否
HY-113953 Z-Asp-CH2-DCB Inhibitor 99.64% 否
HY-118694 TAPI-0 Inhibitor 98.01% 否
HY-131945 CU-115 Antagonist 99.55% 否
HY-155998 NF-κB-IN-11 Inhibitor 98.42% 否
HY-N0617 Sanggenon C 98.50% 否
HY-12326B c-di-AMP diammonium Agonist 99.36% 否
HY-124151 Adenosine-2'-monophosphate Activator 99.91% 否
HY-132248 C5 Lenalidomide Inhibitor 99.62% 否
HY-150725C ODN 1585 sodium Inducer 93.90% 否
HY-N3316 Martynoside Antagonist ≥99.0% 否
HY-100735 C 87 Inhibitor 98.06% 否
HY-135674 SR-318 Inhibitor 99.89% 否
HY-19667A BMS-561392 formate Inhibitor 99.38% 否
HY-120823 PF-05381941 Inhibitor 99.73% 否
HY-162734 BRD5075 Inhibitor 98.08% 否
HY-N2252 Licarin A Inhibitor 98.48% 否
HY-N6253 Pinoresinol Inducer 98.35% 否
HY-102040 Hispidol Inhibitor 98.70% 否
HY-N0358 1,4-Dicaffeoylquinic acid Inhibitor 99.80% 否
HY-N0506 Rosarin 99.94% 否
HY-N1987 Cucurbitacin IIb Inducer 99.74% 否
HY-N3807 Enniatin B1 Inhibitor 99.34% 否
HY-P2612A WP9QY TFA Antagonist 99.83% 否
HY-12326 c-di-AMP Agonist 99.29% 否
HY-133807A (Rac)-Benpyrine Inhibitor 99.30% 否
HY-110077 API-1 99.62% 否
HY-N0907 Ginsenoside Rg6 99.13% 否
HY-N2855 Alphitolic acid ≥97.0% 否
HY-N3063 Pimaric acid 99.83% 否
HY-N4323 14-Deoxyandrographolide Inhibitor 99.47% 否
HY-N6857 Armepavine Inhibitor 99.53% 否
HY-101041 (E)-AG 556 Inhibitor 99.92% 否
HY-112389 p38 MAP Kinase Inhibitor III Inhibitor 98.77% 否
HY-141582 Ceramide 3 ≥98.0% 否
HY-N0857 Deoxyandrographolide Activator 99.87% 否
HY-N0906 Ginsenoside Rk3 Inhibitor 98.85% 否
HY-N9315 Episappanol Inhibitor 98.57% 否
HY-P1825A TNF-α (10-36), human TFA 96.52% 否
HY-P3722A Mca-PLAQAV-Dpa-RSSSR-NH2 TFA 99.21% 否
HY-13740S Resiquimod-d5 99.84% 否
HY-147263 Dovramilast Inhibitor 99.83% 否
HY-150612 (R)-STU104 Inhibitor 99.91% 否
HY-123194 SIRT2/6-IN-1 Inhibitor 98.44% 否
HY-129113 α-​Chaconine Inhibitor 99.04% 否
HY-145498 HDMAPP triammonium Activator ≥90.0% 否
HY-145726A ISIS 104838 sodium 93.70% 否
HY-148454 Necroptosis-IN-3 Inhibitor 99.77% 否
HY-150729 ODN 1982 Inhibitor / 否
HY-N1940 β-Anhydroicaritin Inhibitor 99.09% 否
HY-N4285 Negletein Inhibitor 99.55% 否
HY-P3585 Epobis Inhibitor 99.34% 否
HY-157325 RIPK2-IN-5 Inhibitor 99.73% 否
HY-131707 LEO 39652 Inhibitor 99.51% 否
HY-110246 Quin C1 Agonist 98.47% 否
HY-112456 IKK2-IN-4 Inhibitor 99.89% 否
HY-151966 TD1092 99.49% 否
HY-152959 STING agonist-26 Agonist 99.56% 否
HY-156025 HCAR2 agonist 1 / 否
HY-N2205 Esculentoside H Inhibitor 98.73% 否
HY-N3595 Cleomiscosin A Inhibitor 99.15% 否
HY-N6073 Soyasapogenol A Inhibitor 99.06% 否
HY-N6927 Isoforskolin Inhibitor ≥98.0% 否
HY-P1860A TNF-α (31-45), human TFA / 否
HY-P2320 IDR-1 Inhibitor 99.01% 否
HY-W013675 2-Methoxyhydroquinone Pre-designed Sets / 否
HY-150219A ODN M326 sodium Inhibitor / 否
HY-100376 CPI-1189 Inhibitor 98.49% 否
HY-106359A Delmitide acetate Inhibitor 98.55% 是
HY-108623 Atizoram Inhibitor 96.3% 否
HY-117082 UTL-5g Inhibitor 99.92% 否
HY-118157 3,5,7-Trimethoxyflavone Inhibitor 98.94% 否
HY-12085S Apremilast-d5 98.63% 否
HY-122786 3-O-Methylviridicatin Inhibitor / 否
HY-123936 SR12343 Inhibitor ≥98.0% 否
HY-125527S Resolvin D1-d5 99.2% 否
HY-129151 Ganoderic acid C1 ≥95.0% 否
HY-133807B (R)-Benpyrine 99.17% 否
HY-135808 BIZ 114 Inhibitor ≥98.0% 否
HY-147086 CAY10789 99.84% 否
HY-147506 NOD2 antagonist 1 Antagonist 99.57% 否
HY-147696 SMTIN-T140 99.58% 否
HY-151369 AV123 Inhibitor 99.60% 否
HY-151876 Glucocorticoid receptor modulator 1 99.79% 否
HY-153579 Anti-inflammatory agent 42 Inhibitor ≥98.0% 否
HY-160178 Glucocorticoid receptor agonist-3 Ala-Ala-Mal 99.72% 否
HY-160179 Glucocorticoid receptor agonist-4 Agonist 99.80% 否
HY-161016 TNF/IFN-γ-IN-1 Inhibitor 99.39% 否
HY-169004 CBT-295 Inhibitor 99.34% 否
HY-18754A FR 167653 Inhibitor 99.87% 否
HY-N0569R Madecassic acid (Standard) Inhibitor / 否
HY-N0619A cis-Mulberroside A Inhibitor ≥96.0% 否
HY-N0811 Anemarsaponin B Inhibitor / 否
HY-N8413 Chlojaponilactone B Inhibitor ≥98.0% 否
HY-P1875A TNF-α (46-65), human TFA 99.20% 否
HY-P2612 WP9QY Antagonist / 否
HY-P3149B LEESGGGLVQPGGSMK acetate 99.01% 否
HY-P3203A DSTYSLSSTLTLSK TFA 98.11% 否
HY-114531 Lomifylline 99.67% 否
HY-156060 NCI126224 Inhibitor 99.88% 否
HY-W013557 3-Hydroxyxanthone Inhibitor ≥98.0% 否
HY-131340 LASSBio-1632 Inhibitor / 否
HY-132195 RORγt inverse agonist 14 Inhibitor / 否
HY-19667 BMS-561392 Inhibitor / 否
HY-18862 PF-03715455 Inhibitor / 否
HY-100211A (R)-TAPI-2 Control / 否
HY-100702 SH-5 / 否
HY-101961 Tyrphostin AG 1288 Inhibitor 98.68% 否
HY-106359 Delmitide Inhibitor / 否
HY-108162A Ataquimast Inhibitor / 否
HY-108641 SKF-86002 dihydrochloride Inhibitor / 否
HY-108642A AMG-548 hydrochloride Inhibitor / 否
HY-108953 (S)-Quinolactacine A Inhibitor / 否
HY-111317 SIRT1 activator 3 Activator / 否
HY-114221 Org 48762-0 Inhibitor 99.99% 否
HY-114573 TNF-α-IN-19 Inhibitor / 否
HY-114592 M199 / 否
HY-114981 SRTCX1002 Activator / 否
HY-115351 GW-3333 Inhibitor / 否
HY-115913 PDE4-IN-6 Inhibitor / 否
HY-115976 COX-2-IN-10 Inhibitor / 否
HY-117356A MRS2693 ammonium / 否
HY-118101 15-Deoxy-Δ12,14-prostaglandin A1 / 否
HY-118250A GSK2245035 maleate / 否
HY-120041 ND-2158 Inhibitor / 否
HY-120600 Sibiriline Inhibitor / 否
HY-121401 Myrtenal / 否
HY-121996 Prostaglandin E2 Ethanolamide / 否
HY-122292 Celastramycin A Inhibitor / 否
HY-122521 Sootepin D Inhibitor / 否
HY-123542 ONO-3403 / 否
HY-123736 Ro 32-7315 Inhibitor / 否
HY-124003 Phytomonic acid / 否
HY-124388 PDE4-IN-20 / 否
HY-124954 MN-25 Agonist / 否
HY-126026 NF-κB-IN-17 Inhibitor / 否
HY-126414 Methylenedihydrotanshinquinone / 否
HY-128423AS Tylvalosin-d9 / 否
HY-134950 (E)-C-HDMAPP ammonium Activator / 否
HY-136010 RIP2 Kinase Inhibitor 4 Inhibitor / 否
HY-142069 KB-R7785 Inhibitor / 否
HY-142958 NF-κB-IN-2 / 否
HY-14305 BMS-582949 / 否
HY-143410 Anti-inflammatory agent 16 Inhibitor / 否
HY-144368 CO delivery molecule 1 / 否
HY-144727 Anti-inflammatory agent 11 Inhibitor / 否
HY-144737 Anti-inflammatory agent 15 Inhibitor / 否
HY-145492 Δ7(Z)-C14-HSL / 否
HY-146419 Anti-inflammatory agent 20 Inhibitor / 否
HY-146435 Anti-inflammatory agent 22 Inhibitor / 否
HY-146483 Anti-Aβ agent 1A Inhibitor / 否
HY-146547 Anti-inflammatory agent 17 Inhibitor / 否
HY-146723 IKKβ-IN-1 Inhibitor / 否
HY-146765 AMS-17 Inhibitor / 否
HY-147078 EJMC-1 Inhibitor 99.69% 否
HY-147697 LSD1-IN-21 Inhibitor / 否
HY-147712 PKC-IN-4 Inhibitor / 否
HY-147924 Keap1-Nrf2-IN-11 Inhibitor / 否
HY-147950 PDE4-IN-10 Inhibitor / 否
HY-148606 STING modulator-3 Inhibitor / 否
HY-148908 TNF-α-IN-8 / 否
HY-149331 TNF-α-IN-11 Inhibitor / 否
HY-149485 JNK2-IN-1 Inhibitor / 否
HY-149816 Anti-inflammatory agent 41 Inhibitor / 否
HY-149984 MAO-B-IN-21 Inhibitor / 否
HY-150219 ODN M326 Agonist / 否
HY-150725A Biotin-labeled ODN 1585 sodium / 否
HY-150725B FITC-labeled ODN 1585 sodium Inducer / 否
HY-151188 DHU-Se1 Inhibitor / 否
HY-152213 BET-IN-13 Inhibitor / 否
HY-152957 STING agonist-24 Agonist / 否
HY-152958 STING agonist-25 Agonist / 否
HY-152961 STING agonist-28 Agonist / 否
HY-153329 TNF-α-IN-9 Inhibitor / 否
HY-153330 TNF-α-IN-10 Inhibitor / 否
HY-153952 Immuno modulator-1 Inhibitor / 否
HY-154698 Homouridine / 否
HY-155027 DPP-4-IN-8 Inhibitor / 否
HY-15509 Semapimod Inhibitor / 否
HY-155179 ZMF-23 Inhibitor / 否
HY-155199 PDE1-IN-5 Inhibitor / 否
HY-155243 12R-LOX-IN-1 Inhibitor / 否
HY-155405 Anti-inflammatory agent 64 Inhibitor / 否
HY-155753 Anti-inflammatory agent 50 Inhibitor / 否
HY-155759 HMGB1-IN-2 Inhibitor / 否
HY-155820 Anti-inflammatory agent 54 Inhibitor / 否
HY-155821 Anti-inflammatory agent 55 Inhibitor / 否
HY-15616 BMS-470539 Agonist / 否
HY-156297 β5i-IN-1 Inhibitor / 否
HY-156367 RIPK1-IN-16 Inhibitor / 否
HY-157456 RIPK1-IN-19 Inhibitor ≥98.0% 否
HY-157546 VEGFR-2-IN-40 Inhibitor / 否
HY-157809 Anti-inflammatory agent 74 Inhibitor / 否
HY-157992 LM-021 Inhibitor / 否
HY-159100 PVP-037 Agonist / 否
HY-159516 Sabialimon P Inhibitor / 否
HY-159614 PG-PS Activator / 否
HY-159669 Stercobilin hydrochloride (mixture of isomers) Inhibitor / 否
HY-159884 MG-T-19 / 否
HY-159891 Microtubule destabilizing agent-2 / 否
HY-160027 TNF-alpha-IN-1 Inhibitor / 否
HY-160180 Glucocorticoid receptor agonist-4 Ala-Ala-Mal / 否
HY-160231 ssRNA42 sodium Activator / 否
HY-160433 TNF-α-IN-12 Inhibitor / 否
HY-160434 TNF-α-IN-13 Inhibitor / 否
HY-160435 TNF-α-IN-14 Inhibitor / 否
HY-160436 TNF-α-IN-15 Inhibitor / 否
HY-160437 TNF-α-IN-16 Inhibitor / 否
HY-161240 MAO-B-IN-30 Inhibitor 98.53% 否
HY-161381 PDE4-IN-15 Inhibitor / 否
HY-161520 Glucocorticoid receptor/NF-κB modulator-1 / 否
HY-161620 DW18134 Inhibitor / 否
HY-161629 TLR8 agonist 7 Agonist / 否
HY-161630 TLR8 agonist 8 Agonist / 否
HY-161631 TLR8 agonist 9 Agonist / 否
HY-161674 Monoamine Oxidase B inhibitor 4 Inhibitor / 否
HY-161757 Anti-inflammatory agent 86 / 否
HY-161833 HSP90-IN-31 Inhibitor / 否
HY-161901 BC-1293 Inhibitor / 否
HY-161936 Z21115 Inhibitor / 否
HY-161991 Caspase-3 activator 4 / 否
HY-162097 RIPK1-IN-20 Inhibitor / 否
HY-162116 TLR7 agonist 18 Agonist / 否
HY-162316 NF-κB-IN-15 Inhibitor / 否
HY-162599 Spirohypertone B Inhibitor / 否
HY-162600 CDK8-IN-15 Inhibitor / 否
HY-162641 AF-45 Inhibitor / 否
HY-162649 TIC10g Inhibitor / 否
HY-162797 PDE4-IN-18 Inhibitor / 否
HY-162850 DOR agonist 2 / 否
HY-162861 3-Methyl-chuangxinmycin Inhibitor / 否
HY-162963 PPARδ agonist 11 Agonist / 否
HY-163102 IA-14069 / 否
HY-163280 JGB-1-155 Activator / 否
HY-163368 HDAC6-IN-34 Inhibitor / 否
HY-163670 TLR7 agonist 21 Inhibitor / 否
HY-163673 Glucocorticoid receptor modulator 4 Modulator / 否
HY-163747 VEGFR-2-IN-47 Inhibitor / 否
HY-163748 GSK-3β inhibitor 17 Inhibitor / 否
HY-163755 GPER activator 1 / 否
HY-163777 Talaroterphenyl A Inhibitor / 否
HY-163998 TLR4-IN-1 / 否
HY-164102 TNF-α-IN-18 Inhibitor / 否
HY-164893 ABBV-154 Inhibitor / 否
HY-164894 ABBV-3373 Inhibitor / 否
HY-167877 PS-166276 Inhibitor / 否
HY-168130 TNF-α/IL-1β-IN-1 Inhibitor / 否
HY-168340 COX-2/15-LOX-IN-6 Inhibitor / 否
HY-168734 CB2 receptor agonist 9 Agonist / 否
HY-169103 Neuroprotective agent 5 Inhibitor / 否
HY-169402 PDE1-IN-9 Inhibitor / 否
HY-169417 Euphjatrophane M Inhibitor / 否
HY-169731 RO27-3225 trifluoroacetate Agonist / 否
HY-18759 BMS-751324 Inhibitor / 否
HY-19717S DCVC-13C3,15N / 否
HY-N0041R Ginsenoside Rb3 (Standard) Inhibitor / 否
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / 否
HY-N0066S Eucalyptol-d6 Inhibitor / 否
HY-N0604R Ginsenoside Rh1 (Standard) Inhibitor / 否
HY-N0803S Myrcene-d6 Inhibitor / 否
HY-N0976 1,11b-Dihydro-11b-hydroxymedicarpin / 否
HY-N10009 Cudraflavone B / 否
HY-N10047 7,8-Didehydrocimigenol Inhibitor / 否
HY-N10448 Sinulatumolin E Inhibitor / 否
HY-N10453 Sinulatumolin D / 否
HY-N10454 Sinulatumolin C Inhibitor / 否
HY-N10835 Gnetumontanin B / 否
HY-N11768 4-Methoxylonchocarpin Inhibitor / 否
HY-N11892 7-O-Methylaloesinol Inhibitor / 否
HY-N11996 Aloenin aglycone / 否
HY-N12042 Taxamairin B Inhibitor / 否
HY-N12186 Sibiricine / 否
HY-N12653 Exserohilone Inhibitor / 否
HY-N12743 Farobin A Inhibitor / 否
HY-N13114 8-Gingerdione / 否
HY-N1326 Santamarine / 否
HY-N3364 Lucidone Inhibitor / 否
HY-N3380 Linderaspirone A Inhibitor / 否
HY-N3421 Koaburaside Inhibitor / 否
HY-N3552 Catalposide Inhibitor ≥98.0% 否
HY-N3625 Coronalolic acid Inhibitor / 否
HY-N4061 Hedycoronen A Inhibitor / 否
HY-N4275 Oleaside A / 否
HY-N5054 (R)-5,7-Dimethoxyflavanone Inhibitor ≥99.0% 否
HY-N6969A Dicentrine hydrochloride Antagonist / 否
HY-N7699A D-Trimannuronic acid Activator / 否
HY-N8371 Shizukaol B Inhibitor / 否
HY-N8593 Undecane Inhibitor ≥98.0% 否
HY-N8593S Undecane-d24 / 否
HY-N8816 Stipuleanoside R2 / 否
HY-N8936 Narchinol B / 否
HY-N9000 Loganic acid 6′-O-β-D-glucoside / 否
HY-N9587 Tricin 7-O-β-D-glucopyranoside Inducer / 否
HY-N9699 8α-Hydroxyhirsutinolide Inhibitor / 否
HY-N9867 Gnetifolin E Inhibitor / 否
HY-P10241 Ac-LEHD-CHO Inhibitor / 否
HY-P10350 PapRIV Agonist / 否
HY-P10354 SPA4 / 否
HY-P10693 CZEN-002 Inhibitor / 否
HY-P10770 P-ESBP-DOX Inhibitor / 否
HY-P1832 PTD-p65-P1 Peptide / 否
HY-P1847 IKKγ NBD Inhibitory Peptide / 否
HY-P3149 LEESGGGLVQPGGSMK / 否
HY-P3149A LEESGGGLVQPGGSMK TFA / 否
HY-P3722 Mca-PLAQAV-Dpa-RSSSR-NH2 / 否
HY-RS14784 TNF Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS14785 Tnf Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS14786 TNF Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W010201R Citronellol (Standard) / 否
HY-W014049 N'-Nitro-D-arginine Inhibitor / 否
HY-W1000105 Geranial Inhibitor / 否
HY-W104821 Rosolic acid Activator / 否
HY-101410A SDMA (p-hydroxyazobenzene-p′-sulfonate) / 否
HY-10320A Doramapimod hydrochloride Inhibitor / 否
HY-108162 Ataquimast free base Inhibitor / 否
HY-110133A JTE-607 free base Inhibitor / 否
HY-110343 DBM 1285 dihydrochloride Inhibitor / 否
HY-116426 IDT Modulator / 否
HY-117569 KF24345 free base Inhibitor / 否
HY-117622 ND-2110 Inhibitor / 否
HY-118316 GSK223 Inhibitor / 否
HY-118984 CRX-526 Antagonist / 否
HY-119799 UK-500001 Inhibitor / 否
HY-12085S1 Apremilast-d8 / 否
HY-12085S3 Apremilast-d3 / 否
HY-121200 Azadirone / 否
HY-122566 SMU127 / 否
HY-12348 LEO 29102 Inhibitor / 否
HY-123882 IRAK4-IN-29 / 否
HY-125980 LX-3 Inhibitor / 否
HY-126211 KBH-A42 Inhibitor / 否
HY-126758 Ludartin Inhibitor / 否
HY-130073 Amorfrutin A / 否
HY-134070 2-O-Methyl PAF C-16 Activator / 否
HY-137370 2-Hexynyl-5′-N-ethylcarboxamidoadenosine / 否
HY-138063 Siegeskaurolic acid Inhibitor / 否
HY-141582S Ceramide 3-d3 / 否
HY-156431 Anti-inflammatory agent 61 Inhibitor / 否
HY-158650 10-OAHSA Inhibitor / 否
HY-162579 TLR7 agonist 22 Agonist / 否
HY-163642 TNF-α agonistic 1 / 否
HY-163712 17-Epiestriol Agonist / 否
HY-16658C Z-VA-DL-D-FMK Inhibitor / 否
HY-169118 EGR-1-IN-2 Inhibitor / 否
HY-171034 PQA-18 Inhibitor / 否
HY-20070 BMS-566394 Inhibitor / 否
HY-N1125 Triptobenzene H Inhibitor / 否
HY-N1159 Teuclatriol Inhibitor / 否
HY-N11994 Aloeresin G Inhibitor / 否
HY-N12116 Maceneolignan A Inhibitor / 否
HY-N12905 Celastramycin A (isomer) Inhibitor / 否
HY-N13184 Giraldoid B Inhibitor / 否
HY-N8015S1 Octanal-d2 Inhibitor / 否
HY-N9541 Chaetoglobosin Vb / 否
HY-W015879S 2-Heptanol-d5 Inhibitor / 否
HY-W030338 aPKC-IN-2 / 否
HY-W071581 Glucocorticoid receptor activator 1 Activator / 否
HY-W322573 (R)-Ketoprofen / 否
HY-W505984 TPNA10168 Activator / 否
HY-W753791 (±)-Perillaldehyde / 否
HY-W923189 Neral Inhibitor / 否
HY-18754 FR 167653 free base Inhibitor / 否
抗体抑制剂 (7)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990008 Atrosab 98.00% 否
HY-P99148 Anti-Mouse TNF alpha Antibody (TN3-19.12) Inhibitor 95.00% 否
HY-P9970A Infliximab (Anti-TNF-α) Inhibitor 99.00% 否
HY-P99782 Opinercept Inhibitor / 否
HY-P99565 Tengonermin Inhibitor / 否
HY-P99753 Nerelimomab Inhibitor / 否
HY-P9S0009 Adalimumab (Powder) Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens TNF NCBI NCBI:7124
Canis familiaris TNF NCBI NCBI:403922
Macaca fascicularis TNF NCBI NCBI:102139631
Mus musculus TNF NCBI NCBI:21926
Susscrofa domestica TNF NCBI
Leporidae TNF NCBI
Rattus norvegicus TNF NCBI NCBI:24835
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z